Loading...
01/10 16:36
Loading...
Esperion Therapeutics Inc (ESPR) is set to release its earnings performance on 05/06 04:00:00 in Pre-Market trading. Consensus forecasts predict a revenue of 54.19M and an earnings per share (EPS) of -0.18 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
The earnings call summary reveals strong financial performance with increased royalty revenue and improved coverage approval rates, suggesting growing market confidence. The Q&A section supports this with positive feedback on guideline changes and future growth strategies. Despite flat U.S. revenues, the company has initiatives to drive future growth. The anticipated profitability by Q1 2026, coupled with the strong ESC guidelines reception, further supports a positive outlook. However, the lack of guidance for 2026 introduces some uncertainty, preventing a 'Strong positive' rating.
The earnings call summary and Q&A indicate strong financial performance with a 63% revenue growth and first-time operating income, suggesting effective expense management. The company is on track to exceed revenue consensus, with promising market access and expansion strategies. Although management was vague on some specifics, the strong growth indicators, strategic partnerships, and increased royalty revenues from DSE, combined with optimistic guidance, suggest a positive stock price movement over the next two weeks.
Esperion Therapeutics Inc (ESPR) is scheduled to release its FY2025Q1 earnings report onMay 6, 2025, Pre-Market(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
Analysts' consensus predicts 54.19M in revenue and an EPS of -0.18 for Esperion Therapeutics Inc's FY2025Q1.
Intellectia's exclusive AI algorithms forecast a forEsperion Therapeutics Inc's FY2025Q1 earnings, with a prediction date of May 6, 2025. Esperion Therapeutics Inc
Leverage Intellectia's AI forecast to position trades ahead of theMay 6, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2024-2025 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
Each prediction includes a detailed rationale, key indicator forecasts, and scenario probabilities to guide your trades. For a *Beat*, consider buying call options or shares; for a *Miss*, explore puts or hedging strategies. The prediction card provides actionable suggestions, like specific option strikes or hedging tips, tailored to your risk tolerance. Trade smart and turn insights into profits!
